These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 25177834)
1. Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia. Tardy M; Dold M; Engel RR; Leucht S Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD009227. PubMed ID: 25177834 [TBL] [Abstract][Full Text] [Related]
2. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. Saha KB; Bo L; Zhao S; Xia J; Sampson S; Zaman RU Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010631. PubMed ID: 27045703 [TBL] [Abstract][Full Text] [Related]
3. Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Tardy M; Huhn M; Engel RR; Leucht S Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009230. PubMed ID: 25087165 [TBL] [Abstract][Full Text] [Related]
4. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders. Mahapatra J; Quraishi SN; David A; Sampson S; Adams CE Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001470. PubMed ID: 24915451 [TBL] [Abstract][Full Text] [Related]
5. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Dold M; Samara MT; Li C; Tardy M; Leucht S Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299 [TBL] [Abstract][Full Text] [Related]
6. Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Tardy M; Huhn M; Engel RR; Leucht S Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD009369. PubMed ID: 25290157 [TBL] [Abstract][Full Text] [Related]
7. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. Tardy M; Huhn M; Kissling W; Engel RR; Leucht S Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009268. PubMed ID: 25007358 [TBL] [Abstract][Full Text] [Related]
17. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. Temmingh HS; Williams T; Siegfried N; Stein DJ Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909 [TBL] [Abstract][Full Text] [Related]